期刊文献+

毛细支气管炎患儿血浆尾加压素Ⅱ的变化

The changes of plasma urotensinⅡlevels in children with bronchiolitis
下载PDF
导出
摘要 目的观察毛细支气管炎患儿治疗前后血浆尾加压素Ⅱ(UⅡ)的变化。方法毛细支气管炎组30例,健康对照组30例,放射免疫法检测两组患儿血浆尾加压素Ⅱ含量及毛细支气管炎组治愈后复测血浆UⅡ含量。结果毛细支气管炎组与健康对照组比较,血浆UⅡ含量显著升高(P<0.05),毛细支气管炎组治疗后血浆UⅡ含量显著下降(P<0.05)。结论 UⅡ参与毛细支气管炎的病理生理过程,动态检测UⅡ含量有助于判断毛细支气管炎的病情及预后。 Objective To observe the changes of plasma urotensin Ⅱ levels in children with bronchiolitis before and after the treatment. Methods 30 sampled were taken from Children with Bronchiolitis and normal infants, respectively. Plasma UⅡ levels were determined by radioimmunoassay, and determined again in children with bronchiolitis after treatment. Results Compared with the normal infants, the plasma UⅡ levels were significantiy higher in ohildren with bronchiolitis ( P 〈 0. 05 ), after treatment, the plasma UⅡ levels were significantly decreased in this group ( P 〈 0.05 ). Conclusion Plasma UⅡ plays a role in the pathophysiological process of children with bronchiolitis and monitorin the dynamic changes can predict the degree of children with bronchiolitis.
出处 《中国医学创新》 CAS 2009年第20期28-29,共2页 Medical Innovation of China
关键词 毛细支气管炎 尾加压素Ⅱ Bronchiolitis Urotensin Ⅱ
  • 相关文献

参考文献7

二级参考文献32

  • 1李昌崇,张维溪.儿童哮喘诊断治疗中存在问题探讨[J].临床儿科杂志,2005,23(1):15-17. 被引量:32
  • 2薛全福,谢剑鸣.常压缺氧性大鼠肺动脉高压模型的建立[J].中华结核和呼吸杂志,1989,12(6):350-352. 被引量:157
  • 3孙波 刘文利.右心导管测定大鼠肺动脉压的实验方法[J].中国医学科学院学报,1984,6:465-465.
  • 4Maclean M R, Alexander D, Atirrat A, et al. Contractile responses to human urotensinⅡin rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat[J]. Br J Pharmacol, 2000, 130(2):201 - 204.
  • 5Coulouarn Y, Lihrman I, Jegou S, et al. Cloning of the cDNA encodirg the urotensinⅡprecursor in frog and human reveals intense expression of the urotensinⅡgene in motoneurons of the spinal cord[J]. Proc Natl Acad Sci USA. 1998. 95 (26) : 15803-15808.
  • 6Ames R S, Sarau H M, Chambers J K. Human urotensinⅡis a potent vasoconstrictory and agonist for the orphan receptor GPR14 [J]. Nature,1999, 401(6750): 282-286.
  • 7Russell F D, Meyers D, Galbraith A J, et al. Elevated plasma levels of human urotensin-Ⅱimmunoreactivity in congestive heart failure[J]. Am J Physiol Heart Circ Physiol, 2003, 285(4): H1576 - 1581.
  • 8Stirrat A, Gallagher M, Douglas S A, et al. Potent vasodilator responses to human urotensin Ⅱ in human pulmonary and abdominal resistance arteries[J]. Am J Physiol Heart Cire Physiol, 2001, 280(2): H925 - 928.
  • 9Hederos CA,Janson S,Bornehag CG,et al.The burden of asthma as reflected by the prevalence defined by doctor's diagnosis and the use of healthcare services by preschool children in a Swedish region[J].Acta Pediatr,2002,91 (11):1246-1250.
  • 10Becker A,Lemiere C,Berube D,et al.Summary of recommendations from the Canadian Asthma Consensus guidelines[J].CMAJ,2005,173 (Suppl6):3-11.

共引文献106

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部